LGALS3 and intestinal disorder: The future invention of the Gal3 inhibitor that can target only a specific organ or cell type should be safe and effective to treat a variety of disease conditions; an intestine-specific Gal3 inhibitor could reduce NSAID-induced intestinal ulcers without adverse effects.